2026/2027 | Wilkes University Exam Prep,
Questions, Verified Answers & Detailed
Rationales
NSG 552 PSYCHOPHARMACOLOGY EXAM PREPARATION
Exams 1–3 (2026/2027) | Wilkes University
Verified Practice Questions with Detailed Rationales
═══════════════════════════════════════════════════════
════════════════════════
DOCUMENT OVERVIEW
• This study guide contains rigorously vetted multiple-choice questions covering all
core psychopharmacology content from NSG 552, designed for comprehensive
exam preparation across all three exams with detailed evidence-based rationales
for each correct answer.
• Study this material by working through questions systematically, reviewing
rationales for both correct and incorrect options to strengthen your understanding
of drug mechanisms, clinical applications, adverse effects, and nursing
considerations in psychiatric medication management.
═══════════════════════════════════════════════════════
════════════════════════
QUESTIONS 1–50: NEUROTRANSMITTER SYSTEMS & FUNDAMENTALS
═══════════════════════════════════════════════════════
════════════════════════
1. Which neurotransmitter system is primarily implicated in the
pathophysiology of depression according to the monoamine hypothesis?
A) Glutamate and GABA
B) Serotonin, norepinephrine, and dopamine
C) Acetylcholine and histamine
D) Substance P and neuropeptide Y
E) NMDA and AMPA receptors
,CORRECT ANSWER: B) Serotonin, norepinephrine, and dopamine
RATIONALE: The monoamine hypothesis of depression proposes that a deficiency
in serotonin, norepinephrine, and dopamine neurotransmission underlies
depressive symptoms. Most antidepressant medications work by increasing the
availability of these three monoamine neurotransmitters at the synaptic cleft
through various mechanisms including reuptake inhibition. Glutamate and GABA
are involved in anxiety and seizure disorders. Acetylcholine dysfunction is
associated with cognitive decline. Substance P is involved in pain perception, and
these other systems do not serve as the primary basis of the monoamine
hypothesis.
───────────────────────────────────────────────────────
────────────────────────
2. What is the primary function of the blood-brain barrier in relation to
psychopharmacology?
A) To eliminate all psychotropic drugs from the central nervous system
B) To regulate the passage of lipid-soluble and protein-bound substances into the
brain
C) To increase the half-life of all psychiatric medications
D) To prevent all neurotransmitter reuptake
E) To enhance dopamine synthesis in the mesolimbic pathway
CORRECT ANSWER: B) To regulate the passage of lipid-soluble and protein-
bound substances into the brain
RATIONALE: The blood-brain barrier (BBB) is a selective semipermeable membrane
that permits passage of lipid-soluble substances more readily than hydrophilic
compounds. Most psychotropic drugs must be lipid-soluble to cross the BBB and
reach therapeutic concentrations in the central nervous system. Understanding
BBB permeability is essential for predicting drug efficacy and distribution. The BBB
does not eliminate all drugs, does not regulate half-lives, and does not prevent
neurotransmitter reuptake or affect dopamine synthesis directly.
,───────────────────────────────────────────────────────
────────────────────────
3. Which of the following best describes the concept of receptor affinity in
psychopharmacology?
A) The speed at which a drug produces its therapeutic effect
B) The tendency of a drug to bind to a specific receptor
C) The percentage of receptors occupied by a drug in the brain
D) The metabolic breakdown rate of a psychiatric medication
E) The elimination half-life of a drug in the bloodstream
CORRECT ANSWER: B) The tendency of a drug to bind to a specific receptor
RATIONALE: Affinity refers to the intrinsic ability of a drug molecule to bind to a
specific receptor site, independent of the drug concentration or the number of
receptors available. High affinity means stronger binding; low affinity means
weaker binding. Potency (speed of effect) is different from affinity. Receptor
occupancy refers to the percentage of receptors bound. Metabolic breakdown and
elimination half-life are pharmacokinetic properties unrelated to affinity.
Understanding affinity is critical for predicting drug selectivity and side effect
profiles.
───────────────────────────────────────────────────────
────────────────────────
4. A patient taking an SSRI antidepressant experiences increased serotonin
levels in the synaptic cleft. Which mechanism is responsible for this
pharmacological effect?
A) Inhibition of serotonin synthesis in presynaptic neurons
B) Blocking serotonin reuptake transporters on the presynaptic membrane
C) Increasing the activity of monoamine oxidase (MAO)
D) Stimulating serotonin receptor antagonism
E) Enhancing the release of dopamine to compensate for serotonin
, CORRECT ANSWER: B) Blocking serotonin reuptake transporters on the
presynaptic membrane
RATIONALE: Selective serotonin reuptake inhibitors (SSRIs) work by inhibiting the
serotonin transporter (SERT) on the presynaptic neuron, preventing the
reabsorption (reuptake) of serotonin from the synaptic cleft. This results in
increased serotonin availability and prolonged receptor stimulation. SSRIs do not
inhibit synthesis, increase MAO activity (which would decrease serotonin),
antagonize receptors, or affect dopamine levels. This mechanism explains both the
therapeutic benefits and the delayed onset of action (2-4 weeks) as the system
reaches a new equilibrium.
───────────────────────────────────────────────────────
────────────────────────
5. Which neurotransmitter is most directly associated with positive psychotic
symptoms such as delusions and hallucinations?
A) Serotonin
B) GABA
C) Dopamine (particularly in mesolimbic pathways)
D) Acetylcholine
E) Glutamate
CORRECT ANSWER: C) Dopamine (particularly in mesolimbic pathways)
RATIONALE: The dopamine hypothesis of schizophrenia posits that hyperactivity in
the mesolimbic dopamine pathway contributes to positive symptoms including
delusions, hallucinations, and disorganized behavior. Antipsychotic medications
primarily work through dopamine D2 receptor antagonism. While serotonin
dysfunction can contribute to negative symptoms and depression, and glutamate is
involved in psychotic symptoms, dopamine dysregulation in specific brain regions is
the primary neurobiological basis of acute psychosis. GABA and acetylcholine play
secondary roles.
───────────────────────────────────────────────────────
────────────────────────